Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women

Breast Cancer Research

Volumn 14, Issue 1, 2012, Pages

  Chay, Wen Y ^a   Ong, Whee S ^a   Tan, Puay H ^b   Jie Leo, Nicholas Q ^a   Ho, Gay H ^a   Wong, Chia S ^c   Chia, Kee S ^c   Chow, Khuan Y ^d   Tan Sr, MinHan ^a,e   Ang Sr, Peter ^a,f  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d Health Promotion Board Singapore   (Singapore)

^e INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^f GLENEAGLES HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; FEMALE; FOLLOW UP; GAIL MODEL; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MENARCHE; MODEL; PATIENT COUNSELING; POPULATION RESEARCH; RISK ASSESSMENT; SINGAPORE; VALIDATION STUDY; BIOLOGICAL MODEL; BREAST TUMOR; COHORT ANALYSIS; EARLY DIAGNOSIS; INCIDENCE; MASS SCREENING; MIDDLE AGED; PAGET NIPPLE DISEASE; RADIOGRAPHY; RISK;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, BIOLOGICAL; RISK; RISK ASSESSMENT; SINGAPORE;

EID: 84863393547     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3104     Document Type: Article

References (29)

1. Yew CK, Aizhen J, Yun LE, Ho W. Singapore Cancer Registry, Interim Report, Trends in Cancer Incidence in Singapore, 2004-2008 2010, Singapore: National Registry of Diseases Office, Health Promotion Board.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917. 10.1002/ijc.25516, 21351269.
3. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 2003, 97:1528-1540. 10.1002/cncr.11208, 12627518.
4. Ministry of Health (Singapore) Statistics, Singapore health statistics, Preventive health screening. Ministry of Health (Singapore)., http://www.moh.gov.sg/content/moh_web/home/statistics/Health_Facts_Singapore/Preventive_Health_Screening.html
5. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989, 81:1879-1886. 10.1093/jnci/81.24.1879, 2593165.
6. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998, 90:1371-1388. 10.1093/jnci/90.18.1371, 9747868.
7. Costantino JP, Gail MH, Pee D, Anderson S, Redmond CK, Benichou J, Wieand HS. Validation studies for models projecting the risk of invasive and total breast cancer incidence. J Natl Cancer Inst 1999, 91:1541-1548. 10.1093/jnci/91.18.1541, 10491430.
8. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 2001, 93:358-366. 10.1093/jnci/93.5.358, 11238697.
9. Boyle P, Mezzetti M, La Vecchia C, Franceschi S, Decarli A, Robertson C. Contribution of three components to individual cancer risk predicting breast cancer risk in Italy. Eur J Cancer Prev 2004, 13:183-191. 10.1097/01.cej.0000130014.83901.53, 15167217.
10. Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003, 40:807-814. 10.1136/jmg.40.11.807, 1735317, 14627668.
11. Ulusoy C, Kepenekci I, Kose K, Aydintug S, Cam R. Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor. Breast Cancer Res Treat 2010, 120:419-424. 10.1007/s10549-009-0541-8, 19760030.
12. Trends in cancer incidence in Singapore 1968-2007. Singapore Cancer Registry Report Number 7 2010, Singapore: National Registry of Diseases Office, Health Promotion Board.
13. Ng EH, Ng FC, Tan PH, Low SC, Chiang G, Tan KP, Seow A, Emmanuel S, Tan CH, Ho GH. Results of intermediate measures from a population-based randomised trial of mammographic screening prevalence and detection of breast cancer among Asian women: the Singapore Breast Screening Project. Cancer 1998, 82(8):1521-1528. 10.1002/(SICI)1097-0142(19980415)82:8<1521::AID-CNCR14>3.0.CO;2-6, 9554530.
14. National Cancer Institute Breast Cancer Risk Assessment Tool, SAS codes for Gail model prediction. National Cancer Institute., http://www.cancer.gov/bcrisktool/
15. Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH. Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women. J Natl Cancer Inst 2011, 103:951-961. 10.1093/jnci/djr154, 21562243.
16. Shapiro S, Strax P, Venet L. Evaluation of periodic breast cancer screening with mammography: methodology and early observations. 1966. CA Cancer J Clin 1990, 40:111-125. 10.3322/canjclin.40.2.111, 2106369.
17. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000, 92:1490-1499. 10.1093/jnci/92.18.1490, 10995804.
18. Alexander FE, Anderson TJ, Brown HK, Forrest AP, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 1999, 353:1903-1908. 10.1016/S0140-6736(98)07413-3, 10371567.
19. Andersson I, Aspegren K, Janzon L, Landberg T, Lindholm K, Linell F, Ljungberg O, Ranstam J, Sigfusson B. Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ 1988, 297:943-948. 10.1136/bmj.297.6654.943, 1834636, 3142562.
20. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabar L, Larson LG. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993, 341:973-978. 10.1016/0140-6736(93)91067-V, 8096941.
21. Tabar L, Fagerberg G, Chen HH, Duffy SW, Smart CR, Gad A, Smith RA. Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 1995, 75:2507-2517. 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H, 7736395.
22. Frisell J, Lidbrink E, Hellstrom L, Rutqvist LE. Followup after 11 years--update of mortality results in the Stockholm mammographic screening trial. Breast Cancer Res Treat 1997, 45:263-270. 10.1023/A:1005872617944, 9386870.
23. Bjurstam N, Bjorneld L, Duffy SW, Smith TC, Cahlin E, Eriksson O, Hafstrom LO, Lingaas H, Mattsson J, Persson S, Rudenstam CM, Salander H, Save-Soderbergh J, Wahlin T. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997, 80:2091-2099. 10.1002/(SICI)1097-0142(19971201)80:11<2091::AID-CNCR8>3.0.CO;2-#, 9392331.
24. Decarli A, Calza S, Masala G, Specchia C, Palli D, Gail MH. Gail model for prediction of absolute risk of invasive breast cancer: independent evaluation in the Florence-European Prospective Investigation Into Cancer and Nutrition cohort. J Natl Cancer Inst 2006, 98:1686-1693. 10.1093/jnci/djj463, 17148770.
25. Sim X, Ali RA, Wedren S, Goh DL, Tan CS, Reilly M, Hall P, Chia KS. Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 2006, 6:261. 10.1186/1471-2407-6-261, 1636657, 17078893.
26. Welch HG, Schwartz LM, Woloshin S. Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers. BMJ 2006, 332:727. 1410868, 16565136.
27. Leung GM, Lam TH, Thach TQ, Hedley AJ. Will screening mammography in the East do more harm than good?. Am J Public Health 2002, 92:1841-1846. 10.2105/AJPH.92.11.1841, 1447338, 12406818.
28. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006, CD001877.
29. Welch HG. Overdiagnosis and mammography screening. BMJ 2009, 339:b1425. 10.1136/bmj.b1425, 19589820.